December 4, 2013 | Israeli biomed company CollPlant, which develops various collagen products for the pharmaceutical industry, has announced the signing of a memorandum of understanding with an unnamed US-based company. According to the agreement, CollPlant will receive a total of $6 million for selling the rights to use their collagen production technology for the cosmetics industry.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments